Questions? Email: firstname.lastname@example.org
The Genomic Prostate Score® (GPS) test is performed on a small tissue sample that’s already been taken from your most recent biopsy. Once the sample has arrived at the Exact Sciences lab,* the GPS test measures the activity of the group of cancer-related genes that are in your tumor tissue. The activity of these genes can provide important information about how your specific cancer might behave in the future, including:
- Your level of risk for prostate cancer death
- How likely your cancer is to metastasize with 10 years after surgery
- Your risk for adverse pathology
Has your doctor ordered GPS testing for you?
This short video can help you understand how the results gave prostate cancer patient Dan the confidence to delay his treatment.
of GPS test patients have $0 financial responsibility†
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Your cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurer can confirm if and how the GPS test will be covered.
of GPS test patients have a financial responsibility of <$100†
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patients with high-deductible plans may receive a bill for most or all of the cost of the GPS test if they have not satisfied their deductible.
*Testing performed at an Exact Sciences clinical lab in Redwood City, CA (Genomic Health, Inc.).
†The numbers cited are based on historical patient billing data from 1/02/2021 to 12/31/2021. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages patients to contact their insurer with questions about the GPS test coverage.